Profile
BDSX DHR-PB TMO DHR IDXX A
Company Name Biodesix, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $80.14M $916.76B $160.15B $141.09B $35.45B $30.30B
Employees 0.27K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Mr. Scott Hutton Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
BDSX DHR-PB TMO DHR IDXX A
Quant Rating Score 1 5 3 3 3 3
Quant Rating Strong Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
BDSX DHR-PB TMO DHR IDXX A
Last Close $0.539 $1261.26 $424.24 $197.14 $437.44 $106.28
High 52 $1.96 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $0.49 $1261.26 $419.59 $174.64 $361.04 $99.29
Price vs. 52 Week High -72.5 % 0 % -32.04 % -29.78 % -20.25 % -31.27 %
Price vs. 52 Week Low 10 % 0 % 1.11 % 12.88 % 21.16 % 7.04 %
Total Return
BDSX DHR-PB TMO DHR IDXX A
1 Month Return -28.34 % 0 % -17.41 % -6.31 % 4.72 % -11.36 %
3 Month Return -47.67 % 0 % -26.2 % -19.8 % 0.48 % -29.82 %
6 Month Return -67.13 % 0 % -23.47 % -19.66 % -3.09 % -18.37 %
9 Month Return -68.66 % 0 % -30.12 % -28.03 % -6.87 % -22.6 %
YTD Return -64.77 % 0 % -18.45 % -14.12 % 5.8 % -20.89 %
1 Year Return -56.36 % 0 % -26.04 % -20.05 % -12.39 % -22.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDSX DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.57 % - 0.91 %
Dividend Paid and Capex Coverage Ration (TTM) -14.15 % 2.93 % 4.05 % 2.93 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Growth
BDSX DHR-PB TMO DHR IDXX A
Asset Growth -1.87 % -8.22 % -1.42 % -8.22 % 1.03 % 10.06 %
Gross Profit Growth 97.7 % 1.23 % 5.81 % 1.23 % 8.63 % 2.02 %
Revenue Growth 45.3 % -0.06 % 0.05 % -0.06 % 6.46 % -4.73 %
Revenue 3 Year -72.39 % -21.41 % 12.79 % -21.41 % 25.48 % 8 %
Revenue 5 Year -42.89 % 29.31 % 75.79 % 29.31 % 69.43 % 36.52 %
Revenue 10 Year -28.55 % 14.22 % 164.64 % 14.22 % 219.02 % 7.08 %
EBIT Growth 16.55 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Net Income Growth 17.67 % -18.16 % 5.67 % -18.16 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share 79.63 % -41.24 % -15.42 % -41.24 % 23.4 % 11.67 %
Net Income 5 Yeari Growth Per Share 73.08 % 25.73 % 79.48 % 25.73 % 117.19 % 30.32 %
Net Income 10 Yeari Growth Per Share 66.42 % 42.96 % 248.59 % 42.96 % 493.59 % 197.81 %
Operating Income Growth 16.55 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -112.72 % -6.64 % 3.1 % -6.64 % 2.48 % -1.19 %
Operating 3 Year CFG 63.62 % -22.42 % -6.33 % -22.42 % 27.28 % 23.6 %
Operating 5 Year CFG 55.98 % 64.18 % 82.49 % 64.18 % 111.7 % 85.69 %
Operating 10 Year CFG 43.67 % 69.53 % 244.88 % 69.53 % 379.04 % 182 %
EPS Growth 48.44 % -17.86 % 6.76 % -17.86 % 6.1 % 5.21 %
EPS Diluted Growth 48.44 % -17.08 % 7.06 % -17.08 % 6.26 % 5.73 %
Book Value Per Share 188.64 % -7.44 % 7.15 % -7.44 % 8.46 % 2.3 %
Share Holder 3 Year Equity Growth Per Share -77.67 % 6.35 % 25.29 % 6.35 % 139.34 % 14.73 %
Share Holder 5 Year Equity Growth Per Share 101.8 % 58.77 % 74.85 % 58.77 % 840.53 % 34.5 %
Share Holder 10 Year Equity Growth Per Share 102.16 % 101.9 % 151.37 % 101.9 % 1550.96 % 27.76 %
Dividend Per Share Growth - -6.53 % 12.64 % -6.53 % - 4.82 %
Dividend 3 Year Growth Per Share - 0.35 % 52.23 % 0.35 % - 21.71 %
Dividend 5 Year Growth Per Share - 41.45 % 105.55 % 41.45 % - 44.02 %
Dividend 10 Year Growth Per Share - 221.34 % 158.83 % 221.34 % - 78.77 %
Debt Growth 2.12 % -18.07 % -10.43 % -18.07 % -7.53 % 23.95 %
Free Cash Flow Growth -12.95 % -8.39 % 4.91 % -8.39 % 3.26 % -6.85 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
BDSX DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 78.17 % 59.74 % 41.74 % 59.74 % 61.08 % 53.97 %
Return on Assets TTM -44.15 % 4.76 % 6.58 % 4.76 % 26.96 % 10.57 %
Return on Equity TTM -216.03 % 7.47 % 13.34 % 7.47 % 55.82 % 20.95 %
Return on Capital Employed TTM -41.44 % 6.66 % 8.53 % 6.66 % 50.78 % 14.73 %
Net Income Per EBT TTM 100 % 83.59 % 92.18 % 83.59 % 80 % 84.78 %
EBT Per Ebit TTM 124.93 % 93.35 % 96.45 % 93.35 % 98.21 % 100.34 %
EBIT Per Revenue TTM -48.18 % 20.26 % 17.08 % 20.26 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM -78.56 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Receivables Turnover TTM 8.29 6.79 5.07 6.79 6.94 4.92
Payables Turnover TTM 7.1 5.57 - 5.57 13.28 5.5
Inventory Turnover TTM - 3.79 4.78 3.79 3.97 3.02
Fixed Asset Turnover TTM 241 % 466.14 % 459.74 % 466.14 % 470 % 359.75 %
Asset Turnover TTM 73.34 % 30.11 % 43.31 % 30.11 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM -0.38 8.72 21.53 8.72 11.29 5.95
Free Cash Flow Per Share TTM -0.4 6.84 17.79 6.84 9.7 4.94
Cash Per Share TTM 20.24 % 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM -68.26 % 26.23 % 18.97 % 26.23 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 107.07 % 78.46 % 82.61 % 78.46 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM -78.56 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Price To Free Cash Flows Ratio TTM -1.54 28.68 23.82 28.78 44.42 21.51
Price To Operating Cash Flows Ratio TTM -1.46 22.53 19.7 22.6 38.75 17.85
Price Cash Flow Ratio TTM -1.46 22.53 19.7 22.6 38.75 17.85
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
ADVB Advanced Biomed Inc. Common Stock 1.81
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BIAF bioAffinity Technologies, Inc. 0.499
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
DHR Danaher Corporation 197.14
ETFs With Exposure to BDSX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
VXF Vanguard Extended Market Index Fund 0 170
IWC iShares Micro-Cap ETF 0.00465 110.33
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 92.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 92.07
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.34
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.33
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.33
VTSAX Vanguard Total Stock Market Index Fund 0 131.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VITSX Vanguard Total Stock Market Index Fund 0 131.83
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000126283 92.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.3
Unlock